| Therapeutic antibodies against viral hepatitis. | |
| | |
MedLine Citation:
|
PMID: 12772504 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Antibodies have the potential to be immunotherapeutic agents, used either as stand-alone therapy or as an adjunct for managing chronic viral infection. In addition, antibodies may be used prophylactically in individuals who have been accidentally exposed to hepatitis B virus (HBV) or hepatitis C virus (HCV), or to prevent re-infection of the liver in patients who have undergone liver transplantation. Human monoclonal antibodies to HBV and HCV were generated and their ability to reduce viral load was tested in different animal model systems, the Trimera mouse model and HBV-carrier chimpanzees. These antibodies were further developed and are currently being studied in clinical trials for chronic HBV or HCV and in liver transplant patients. The antibodies were shown to be safe, tolerable and could significantly reduce viral load. Their ability to inhibit HCV re-infection in the transplanted liver is being evaluated. |
| | |
Authors:
|
Shlomo Dagan; Rachel Eren |
Related Documents
:
|
10385664 - The long-term course of chronic hepatitis b. 12211714 - Influence of hbv or hcv associated chronic liver diseases on the course and outcome of ... 17162434 - Prevalence of occult hepatitis b and hepatitis c virus infections in turkish hemodialys... 23018374 - Mediation of hiv/sti risk by mental health disorders among persons living in the us rep... 8935484 - Trichinella infection and clinical disease. 3672104 - Haemophilia, blood products and hiv infection. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current opinion in molecular therapeutics Volume: 5 ISSN: 1464-8431 ISO Abbreviation: Curr. Opin. Mol. Ther. Publication Date: 2003 Apr |
Date Detail:
|
Created Date: 2003-05-29 Completed Date: 2003-07-28 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 100891485 Medline TA: Curr Opin Mol Ther Country: England |
Other Details:
|
Languages: eng Pagination: 148-55 Citation Subset: IM |
Affiliation:
|
XTL Biopharmaceuticals Ltd., Kiryat Weizmann Science Park, Rehovot 76100, Israel. sdagan@xtlbio.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antibodies, Monoclonal / immunology*, therapeutic use* Hepatitis Antibodies / immunology*, therapeutic use* Hepatitis B / immunology, therapy* Hepatitis C / immunology, therapy* Humans Immunotherapy* Mice Pan troglodytes |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Hepatitis Antibodies |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Therapeutic recombinant proteins: trends in US approvals 1982 to 2002.
Next Document: Monoclonal antibodies to two epitopes of beta-human chorionic gonadotropin for the treatment of canc...